Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: Associations to future good radiographic and physical outcomes
Annals of Rheumatic Diseases Jun 28, 2018
Sundlisæter NP, et al. - Authors gauged the relationships between remission based on clinical and ultrasound definitions, and future good radiographic and physical outcome in early rheumatoid arthritis (RA). As per data, American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Boolean remission based on 44 joints was suggested to be the preferred treatment target in early RA. Experts noted an association of absence of ultrasound inflammation with no radiographic progression.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries